Literature DB >> 12368331

Biology of ovine adenovirus infection of nonpermissive cells.

Daniel Kümin1, Christian Hofmann, Michael Rudolph, Gerald W Both, Peter Löser.   

Abstract

Nonhuman adenoviruses, including those of the genus Atadenovirus, have the potential to serve as vectors for vaccine and gene therapy applications in humans, since they are resistant to preexisting immunity induced by human adenoviruses in the majority of the population. In this study, we elucidate the outcome of infection by ovine adenovirus type 7 isolate 287 (OAdV) of several nonovine cell types. We show here that OAdV infects a wide range of nonovine cells but is unable to complete its replication cycle in any of them. In nonovine, nonfibroblast cells, viral replication is blocked at an early stage before the onset of, or early in, DNA replication. Some fibroblasts, on the other hand, allow viral DNA replication but block virus production at a later stage during or after the translation of late viral proteins. Late viral proteins are expressed in cells where viral DNA replication takes place, albeit at a reduced level. Significantly, late proteins are not properly processed, and their cellular distribution differs from that observed in infected ovine cells. Thus, our results clearly show that OAdV infection of all nonovine cells tested is abortive even if significant viral DNA replication occurs. These findings have significant positive implications with respect to the safety of the vector system and its future use in humans.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12368331      PMCID: PMC136640          DOI: 10.1128/jvi.76.21.10882-10893.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

Review 1.  Mechanism of DNA replication in eukaryotic cells: cellular host factors stimulating adenovirus DNA replication.

Authors:  R N de Jong; P C van der Vliet
Journal:  Gene       Date:  1999-08-05       Impact factor: 3.688

2.  Complementation of a defective human adenovirus by an otherwise incompatible ovine adenovirus recombinant carrying a functional E1A gene.

Authors:  Linda J Lockett; Gerald W Both
Journal:  Virology       Date:  2002-03-15       Impact factor: 3.616

3.  Transformation of mammalian cells by avian myelocytomatosis virus and avian erythroblastosis virus.

Authors:  K Quade
Journal:  Virology       Date:  1979-10-30       Impact factor: 3.616

4.  Post-transcriptional restriction of human adenovirus expression in monkey cells.

Authors:  L Eron
Journal:  J Virol       Date:  1975-05       Impact factor: 5.103

5.  The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12.

Authors:  J V Maizel; D O White; M D Scharff
Journal:  Virology       Date:  1968-09       Impact factor: 3.616

6.  Nonproductive infection of baby hamster kidney cells (BHK21) with adenovirus type 12.

Authors:  W Doerfler
Journal:  Virology       Date:  1969-08       Impact factor: 3.616

7.  Cellular and early viral factors in the interaction of adenovirus type 12 with hamster cells: the abortive response.

Authors:  M Hösel; J Schröer; D Webb; E Jaroshevskaja; W Doerfler
Journal:  Virus Res       Date:  2001-12-04       Impact factor: 3.303

8.  Characterization of a new human diploid cell strain, IMR-90.

Authors:  W W Nichols; D G Murphy; V J Cristofalo; L H Toji; A E Greene; S A Dwight
Journal:  Science       Date:  1977-04-01       Impact factor: 47.728

9.  Block to multiplication of adenovirus serotype 2 in monkey cells.

Authors:  D F Klessig; C W Anderson
Journal:  J Virol       Date:  1975-12       Impact factor: 5.103

Review 10.  Advances in the development of non-human viral DNA-vectors for gene delivery.

Authors:  Peter Löser; Andreas Hüser; Moritz Hillgenberg; Daniel Kümin; Gerald W Both; Christian Hofmann
Journal:  Curr Gene Ther       Date:  2002-05       Impact factor: 4.391

View more
  6 in total

1.  Induction of both cellular and humoral immunity following a rational prime-boost immunization regimen that incorporates recombinant ovine atadenovirus and fowlpox virus.

Authors:  Cara K Fraser; Kerrilyn R Diener; Erin L Lousberg; Gerald W Both; Larry Ward; Michael P Brown; John D Hayball
Journal:  Clin Vaccine Immunol       Date:  2010-09-01

Review 2.  Circumventing antivector immunity: potential use of nonhuman adenoviral vectors.

Authors:  Estrella Lopez-Gordo; Iva I Podgorski; Nicholas Downes; Ramon Alemany
Journal:  Hum Gene Ther       Date:  2014-03-25       Impact factor: 5.695

3.  Construction, rescue, and characterization of vectors derived from ovine atadenovirus.

Authors:  Peter Löser; Christian Hofmann; Gerald W Both; Wolfgang Uckert; Moritz Hillgenberg
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

Review 4.  Development of nonhuman adenoviruses as vaccine vectors.

Authors:  Dinesh S Bangari; Suresh K Mittal
Journal:  Vaccine       Date:  2005-09-23       Impact factor: 3.641

Review 5.  COVID-19 Vaccine Frontrunners and Their Nanotechnology Design.

Authors:  Young Hun Chung; Veronique Beiss; Steven N Fiering; Nicole F Steinmetz
Journal:  ACS Nano       Date:  2020-10-09       Impact factor: 15.881

Review 6.  Understanding Post Entry Sorting of Adenovirus Capsids; A Chance to Change Vaccine Vector Properties.

Authors:  Coralie F Daussy; Noémie Pied; Harald Wodrich
Journal:  Viruses       Date:  2021-06-24       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.